InVivo Therapeutics’ CEO Frank Reynolds Scheduled to Appear on St. Louis’ Fox 2 News in the Morning

print this article - email to a friend - join our eNewsletter
Submitted by admin on 3/7/2012 @ 3:00 AM
Companies mentioned in this article: InVivo Therapeutics Holdings Corp.
CAMBRIDGE, Mass. -- (BUSINESS WIRE) -- InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that CEO Frank Reynolds is scheduled to appear on KTVI-TV’s Fox 2 News in the Morning at 7:40 am CDT on Monday, March 12th in St. Louis, MO.